Fourfold increase in prevalence of gestational diabetes mellitus after adoption of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria

Huhn, Evelyn A.; Massaro, Nadine; Streckeisen, Simone; Manegold-Brauer, Gwendolin; Schoetzau, Andreas; Schulzke, Sven; Winzeler, Bettina; Hoesli, Irène; Lapaire, Olav

doi:10.1515/jpm-2016-0099

Cited by 40 publications

(31 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The reported figure for frequency of GDM goes in hand with Ma et al (30) , Karcaaltincaba et al (31) and Arbib et al (32) who reported frequencies of 12.2%, 11.1% and 9.9%, respectively for GDM. Moreover, Huhn et al (33) and Brown & Wyckoff (34) documented that the introduction of the IADPSG criteria resulted in an absolute increase of GDM prevalence of 8.5% (33) and a 1.03-3.78-fold rise versus baseline criteria (34) .…”

Section: Discussion:-mentioning

confidence: 99%

Serum Adropin and Adipose Fatty-Acid Binding Protein at 6th Week of Pregnancy Are Significant Predictors for Development of Insulin Resistance at the 24th Week.

Sharafeldeen¹

2018

IJAR

View full text Add to dashboard Cite

Section: Discussion:-mentioning

confidence: 99%

Serum Adropin and Adipose Fatty-Acid Binding Protein at 6th Week of Pregnancy Are Significant Predictors for Development of Insulin Resistance at the 24th Week.

Sharafeldeen¹

2018

IJAR

View full text Add to dashboard Cite

“…The prevalence of GDM diagnosed by IADPSG criteria has been reported as 17.6%, 4.2%, 11.8%, 9.5%, 23.3%, 8.6%, and 45% in Singapore, Greenland, Switzerland, South Korea, Sri Lanka, Sub‐Saharan Africa, and the United Arab Emirates, respectively. By contrast, a two‐step approach for diagnosis determined a GDM prevalence of 3.3% in Switzerland and 12% in the United Arab Emirates . This approximately fourfold increase in prevalence of GDM determined by the IADPSG criteria is similar to the present findings.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of gestational diabetes mellitus evaluated by universal screening with a 75‐g, 2‐hour oral glucose tolerance test and IADPSG criteria

Karçaaltıncaba

Çalış

Ocal

et al. 2017

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Objective To determine the prevalence of gestational diabetes mellitus (GDM) and its association with maternal age among Turkish women diagnosed by International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria. Methods A cross‐sectional study was conducted in 2013–2015 among non‐diabetic pregnant women aged 18–49 years who were universally screened for GDM by IADPSG criteria. The percentage of women meeting each diagnostic threshold and the prevalence of GDM by age group were calculated. Linear trends were evaluated by logistic regression. Results Among 1434 women screened, 159 (11.1%, 95% confidence interval 9.5%–12.7%) were diagnosed with GDM; eleven of these women had been diagnosed according to a fasting glucose level in the first trimester. The prevalence of GDM was 6.6% (10/151), 7.3% (37/507), 8.8% (42/479), 16.7% (45/270), and 35.2% (25/71) among women aged younger than 25, 25–29, 30–34, 35–39, and 40 years or older, respectively. GDM prevalence increased with age (P<0.001). The numbers of women diagnosed with GDM in the second trimester who exceeded one, two, and three thresholds of the 2‐hour oral glucose tolerance test were 66 (44.6%), 52 (35.1%), and 30 (20.3%), respectively. Conclusion Prevalence of GDM was correlated with maternal age. Most women diagnosed in the second trimester exceeded the threshold at only one of the three timepoints.

show abstract

“…Consultation of the case history indicated that this pregnant woman had been diagnosed with GDM at the time of blood sampling [19]. GDM is a unique form of glucose intolerance, being of a transient nature and only occurring during pregnancy in women with no prior history of diabetes [68][69][70]. GDM shares a number of features in common with T2DM, such as a systemic inflammation associated with the metabolic syndrome.…”

Section: Infiltrating Pmn Alter Placental Function In Gdm Via the Actmentioning

confidence: 99%

The role of neutrophil activation in determining the outcome of pregnancy and modulation by hormones and/or cytokines

Hahn

Harmatz

Vokálová

et al. 2019

Clinical and Experimental Immunology

View full text Add to dashboard Cite

Neutrophils are often exclusively considered as a first-line innate immune defence, able to rapidly kill or trap pathogens and causing in case of over-activation tissue damage. In the female reproductive tract, however, the presence and activity of neutrophils seems to be tightly regulated. Major players in orchestrating this regulation are cyclical steroid sex hormones present during the menstrual cycle and pregnancy. This review describes the role of sex hormones in regulating directly or indirectly the functionality of neutrophils, the role of neutrophils during fertilization and pregnancy and in controlling viral, fungal and bacterial infection. This review also discusses the consequence of overt neutrophil activation in pregnancy pathologies.Our intention in this review is to highlight new observations made during discrete stages of the reproductive cycle, focusing particularly on the role of sex hormones and cytokines in modulating neutrophil activity and their potential dysregulation in pathology.

show abstract

Fourfold increase in prevalence of gestational diabetes mellitus after adoption of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria

Cited by 40 publications

References 20 publications

Serum Adropin and Adipose Fatty-Acid Binding Protein at 6th Week of Pregnancy Are Significant Predictors for Development of Insulin Resistance at the 24th Week.

Serum Adropin and Adipose Fatty-Acid Binding Protein at 6th Week of Pregnancy Are Significant Predictors for Development of Insulin Resistance at the 24th Week.

Prevalence of gestational diabetes mellitus evaluated by universal screening with a 75‐g, 2‐hour oral glucose tolerance test and IADPSG criteria

The role of neutrophil activation in determining the outcome of pregnancy and modulation by hormones and/or cytokines

Contact Info

Product

Resources

About